دورية أكاديمية
أعرض في EDS

Demographic trends of cardiorenal and heart failure deaths in the United States, 2011-2020.

التفاصيل البيبلوغرافية
العنوان: Demographic trends of cardiorenal and heart failure deaths in the United States, 2011-2020.
المؤلفون: Shearer JJ; Heart Disease Phenomics Laboratory, Epidemiology and Community Health Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, United States of America., Hashemian M; Heart Disease Phenomics Laboratory, Epidemiology and Community Health Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, United States of America., Nelson RG; Chronic Kidney Disease Section, Phoenix Epidemiology & Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Arizona, United States of America., Looker HC; Chronic Kidney Disease Section, Phoenix Epidemiology & Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Arizona, United States of America., Chamberlain AM; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, United States of America.; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, United States of America., Powell-Wiley TM; Social Determinants of Obesity and Cardiovascular Risk Laboratory, Cardiovascular Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, United States of America.; Intramural Research Program, National Institute on Minority Health and Health Disparities, National Institutes of Health, Bethesda, Maryland, United States of America., Pérez-Stable EJ; Minority Health and Health Disparities Population Laboratory, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, United States of America., Roger VL; Heart Disease Phenomics Laboratory, Epidemiology and Community Health Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
المصدر: PloS one [PLoS One] 2024 May 29; Vol. 19 (5), pp. e0302203. Date of Electronic Publication: 2024 May 29 (Print Publication: 2024).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
أسماء مطبوعة: Original Publication: San Francisco, CA : Public Library of Science
مواضيع طبية MeSH: Heart Failure*/mortality , Heart Failure*/epidemiology , Cardio-Renal Syndrome*/mortality , Cardio-Renal Syndrome*/epidemiology, Humans ; Male ; United States/epidemiology ; Female ; Aged ; Middle Aged ; Adult ; Aged, 80 and over ; Adolescent ; Young Adult ; Risk Factors
مستخلص: Background: Heart failure (HF) and kidney disease frequently co-occur, increasing mortality risk. The cardiorenal syndrome results from damage to either the heart or kidney impacting the other organ. The epidemiology of cardiorenal syndrome among the general population is incompletely characterized and despite shared risk factors with HF, differences in mortality risk across key demographics have not been well described. Thus, the primary goal of this study was to analyze annual trends in cardiorenal-related mortality, evaluate if these trends differed by age, sex, and race or ethnicity, and describe these trends against a backdrop of HF mortality.
Methods and Findings: The Centers for Disease Control and Prevention Wide-ranging ONline Data for Epidemiologic Research database was used to examine cardiorenal- and HF-related mortality in the US between 2011and 2020. International Classification of Diseases, 10 Revision codes were used to classify cardiorenal-related deaths (I13.x) and HF-related deaths (I11.0, I13.0, I13.2, and I50.x), among decedents aged 15 years or older. Decedents were further stratified by age group, sex, race, or ethnicity. Crude and age-adjusted mortality rates (AAMR) per 100,000 persons were calculated. A total of 97,135 cardiorenal-related deaths and 3,453,655 HF-related deaths occurred. Cardiorenal-related mortality (AAMR, 3.26; 95% CI: 3.23-3.28) was significantly lower than HF-related mortality (AAMR, 115.7; 95% CI: 115.6-115.8). The annual percent change (APC) was greater and increased over time for cardiorenal-related mortality (2011-2015: APC, 7.1%; 95% CI: 0.7-13.9%; 2015-2020: APC, 19.7%, 95% CI: 16.3-23.2%), whereas HF-related mortality also increased over that time period, but at a consistently lower rate (2011-2020: APC, 2.4%; 95% CI: 1.7-3.1%). Mortality was highest among older and male decedents for both causes. Cardiorenal-related deaths were more common in non-Hispanic or Latino Blacks compared to Whites, but similar rates were observed for HF-related mortality. A larger proportion of cardiorenal-related deaths, compared to HF-related deaths, listed cardiorenal syndrome as the underlying cause of death (67.0% vs. 1.2%).
Conclusions: HF-related deaths substantially outnumber cardiorenal-related deaths; however, cardiorenal-related deaths are increasing at an alarming rate with the highest burden among non-Hispanic or Latino Blacks. Continued surveillance of cardiorenal-related mortality trends is critical and future studies that contain detailed biomarker and social determinants of health information are needed to identify mechanisms underlying differences in mortality trends.
Competing Interests: The authors have declared that no competing interests exist.
(Copyright: This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.)
References: Kidney Med. 2023 Mar 09;5(5):100624. (PMID: 37143487)
Nat Rev Nephrol. 2022 Nov;18(11):696-707. (PMID: 36104509)
JACC Heart Fail. 2016 Nov;4(11):885-893. (PMID: 27395346)
BMJ. 2021 Mar 23;372:n461. (PMID: 33758001)
Circ Heart Fail. 2020 Aug;13(8):e007264. (PMID: 32787445)
Nat Rev Nephrol. 2016 Oct;12(10):610-23. (PMID: 27573728)
Vital Health Stat 2. ;(172):1-21. (PMID: 28436642)
Nat Med. 2022 Mar;28(3):583-590. (PMID: 35132265)
Circulation. 2018 Aug 28;138(9):929-944. (PMID: 30354446)
J Am Coll Cardiol. 2008 Nov 4;52(19):1527-39. (PMID: 19007588)
Eur Heart J. 2010 Mar;31(6):703-11. (PMID: 20037146)
Eur Heart J. 2014 Feb;35(7):455-69. (PMID: 24164864)
Curr Opin Cardiol. 2021 May 1;36(3):320-328. (PMID: 33741769)
JAMA Cardiol. 2022 Sep 1;7(9):900-904. (PMID: 35895048)
J Am Soc Echocardiogr. 2022 Apr;35(4):395-407. (PMID: 34915133)
Stat Med. 2000 Feb 15;19(3):335-51. (PMID: 10649300)
Prev Med Rep. 2020 Sep 01;20:101193. (PMID: 33101883)
Nat Rev Nephrol. 2022 Feb;18(2):84-94. (PMID: 34750551)
J Am Coll Cardiol. 2004 Jan 7;43(1):61-7. (PMID: 14715185)
J Family Med Prim Care. 2020 Aug 25;9(8):4127-4133. (PMID: 33110820)
Popul Health Metr. 2014 Apr 10;12(1):10. (PMID: 24716810)
J Am Soc Nephrol. 2015 Oct;26(10):2504-11. (PMID: 25733525)
J R Soc Med. 2016 Jan;109(1):12-7. (PMID: 26609123)
JAMA Netw Open. 2018 Nov 2;1(7):e184412. (PMID: 30646390)
PLoS One. 2021 Mar 3;16(3):e0246813. (PMID: 33657143)
Circulation. 2020 Mar 3;141(9):e139-e596. (PMID: 31992061)
JACC Heart Fail. 2022 Nov;10(11):851-859. (PMID: 36328654)
Circulation. 2021 Mar 16;143(11):1157-1172. (PMID: 33720773)
Circulation. 2019 Apr 16;139(16):e840-e878. (PMID: 30852913)
Nat Rev Nephrol. 2013 Feb;9(2):99-111. (PMID: 23247571)
Front Public Health. 2023 Jan 17;10:1074017. (PMID: 36733284)
Kidney Med. 2022 Dec 28;5(3):100597. (PMID: 36814454)
Circulation. 2022 Feb 22;145(8):e153-e639. (PMID: 35078371)
Natl Vital Stat Rep. 1998 Oct 7;47(3):1-16, 20. (PMID: 9796247)
J Clin Med. 2021 Jul 31;10(15):. (PMID: 34362216)
Mayo Clin Proc Innov Qual Outcomes. 2023 Jun;7(3):194-202. (PMID: 37229286)
Eur Heart J. 2019 Dec 14;40(47):3859-3868c. (PMID: 31800034)
Can J Cardiol. 2008 Jul;24 Suppl B:25B-9B. (PMID: 18629386)
BMC Public Health. 2021 Jun 1;21(1):1031. (PMID: 34074276)
BMC Cardiovasc Disord. 2017 Jul 18;17(1):192. (PMID: 28720073)
Heart Fail Rev. 2004 Jul;9(3):195-201. (PMID: 15809817)
تواريخ الأحداث: Date Created: 20240529 Date Completed: 20240529 Latest Revision: 20240531
رمز التحديث: 20240531
مُعرف محوري في PubMed: PMC11135744
DOI: 10.1371/journal.pone.0302203
PMID: 38809898
قاعدة البيانات: MEDLINE
الوصف
تدمد:1932-6203
DOI:10.1371/journal.pone.0302203